VNRX
$3.12
Volitionrx
($.12)
(3.70%)
VNRX
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.14)
Revenue:  $5.00 Mil
Thursday
Nov 12
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when VNRX reports earnings?
Beat
Meet
Miss

Where is VNRX's stock price going from here?
Up
Flat
Down
Stock chart of VNRX
Analysts
Summary of analysts' recommendations for VNRX
Score
Grade
Pivots
Resistance
$4.03
$3.82
$3.53

$3.32

Support
$3.03
$2.82
$2.53
Tweet
Growth
Description
Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.
Peers
Myriad GeneticsImmunomedicsQuidelCareDxMeridian BioscienceSurModics